Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

EBCC 6 2008 /
EBCC 6: The importance of epigenetics in the future direction or breast cancer treatment

15th - 19th Apr 2008

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 03.12.08
Views: 14450
Rating:

Prof. Anne-Lise Børresen-Dale - President of European Association of Cancer Research (EACR)

Prof. Anne-Lise Børresen-Dale, President of European Association of Cancer Research (EACR).

Prof. Børresen-Dale discusses the importance of a multi-discipline approach to cancer treatment. It is still unclear which of epidemiology and genetics is a more significant causative factor of breast cancer.

How can we affect the chance of breast cancer, weather this is though lifestyle changes, such as reducing obesity, or through chemo-prevention. Genetics can be very important to identify populations that are at risk and chemo prevention should be targeted at these populations.

Prof. Børresen-Dale goes on to stress the importance of a multi-discipline approach among researchers and clinicians. For instance exchange programmes can be used to educate laboratory researchers of surgical procedures.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation